Babcock confident about bid pipeline after strong first half

Babcock hiked its interim dividend by over a tenth after hitting analysts' forecasts in the first half, and said it is confident of meeting full-year expectations as its order book remains strong.

Babcock hiked its interim dividend by over a tenth after hitting analysts' forecasts in the first half, and said it is confident of meeting full-year expectations as its order book remains strong.

The firm, which provides engineering support services to the defence, energy, telecommunications, transport and education sectors, reported underlying revenue from continuing operations of £1,556.7m in the six months to September 30th, up 6% from the £1,472.0m registered in the first half of last year.

Organic revenue growth came in at 7.3% during the half, an acceleration from the 6% increase seen in the second half of the last fiscal year, and well ahead of the 6.5% growth expected by Jefferies.

The firm said that the Support Services division was the main driver of growth during the period, delivering organic growth of 18% as contract awards in the preceding six months became operational. Marine and Technology increase organic revenues by 5%, as expected.

"Babcock's strong first half performance reflects our leadership in UK engineering support services, the continuing growth in our major markets and our increasing international presence," said Chief Executive Peter Rogers.

Pre-tax profit rose 13% from £126.3 to £142.7m, while basic earnings per share (EPS) improved by 14% from 28.52p to 32.40p, which Jefferies said was in line with expectations. The dividend for the first half was raised by 10.5% from 5.7p per share to 6.3p per share.

The order book rose from £12bn to £12.5bn year-on-year which provides "excellent visibility of future revenue streams", Babcock said. Meanwhile, the bid pipeline increase from £9.5bn to over £13bn.

Rogers added: "The strength of our order book and bid pipeline underpin our confidence in the future."

The firm's outlook for the Defence markets in particular was pretty bullish, as it explained that strategic reviews in the Ministry of Defence (MoD) have created many opportunities. As the MoD focuses on building a platform with its 'Future Force 2020' strategy, Babcocks' expects that a number of initiatives it has been discussing with its customers over the past few years will start to come to market; "we have seen some evidence of this during the first half".

Net debt reduced from £678.8m last year to £581.1m by the end of the first half bring the net debt-to-EBITDA annualised ratio down from 2.0 to 1.7. [EBITDA: earnings before interest, tax, depreciation and amortisation]

Analysts' views

Jefferies reiterated its 'buy' rating for the stock this morning, saying that the group has the medium-term outlook remains "impressive".

"Babcock is tracking significant opportunities that are expected to move into the bid pipeline over the next one-two years. In particular we sense that momentum has accelerated within the nuclear and defence markets in recent months.

"The scale of these opportunities underpin our confidence that Babcock can return to 10%+ organic revenue growth in FY13E-FY14E."

Recommended

Share tips of the week – 19 August
Share tips

Share tips of the week – 19 August

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
19 Aug 2022
How to invest in smart factories as the “fourth industrial revolution” arrives
Share tips

How to invest in smart factories as the “fourth industrial revolution” arrives

Exciting new technologies and trends are coming together to change the face of manufacturing. Matthew Partridge looks at the companies that will drive…
18 Aug 2022
How to invest today? Look to the past, not the future
Investment strategy

How to invest today? Look to the past, not the future

The past few years have seen so many changes to our way of life that many people said we had entered a “new normal”. But as it turns out, the new norm…
18 Aug 2022
A new legal headache for Haleon
Stocks and shares

A new legal headache for Haleon

Haleon, GSK’s former consumer-products arm, spun off last month, has made a dismal debut on the stockmarket.
17 Aug 2022

Most Popular

How to protect your wealth as inflation hits new record highs
Investment strategy

How to protect your wealth as inflation hits new record highs

UK inflation has hit a new record high of 10.1%. It's going to hurt, says Dominic Frisby. Here's how you can protect your wealth.
17 Aug 2022
How to cut your energy bill
Personal finance

How to cut your energy bill

The energy-price cap will almost double in the autumn. What does this mean for your money, and how can you alleviate the squeeze? Ruth Jackson-Kirby h…
17 Aug 2022
Are GSK’s legal troubles a threat to the firm’s survival?
Biotech stocks

Are GSK’s legal troubles a threat to the firm’s survival?

Pharmaceutical giant GlaxoSmithKline is facing legal action over heartburn drug Zantac that has seen billions wiped off its market value. Rupert Hargr…
16 Aug 2022